×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

ÏÙ²¡¶¾¹¹½¨Ð§ÀÍ

2017-06-20
|
»á¼ûÁ¿£º

Ò»¡¢ÊÖÒÕ¼ò½é£º

ÖØ×éÏÙ²¡¶¾£¨Adenovirus£©ÊÇÒ»ÖÖÏÖÔÚ×î¸ßЧ¿É¿¿µÄÖØ×鲡¶¾±í´ïϵͳ֮һ £¬¿ÉÓÃÓÚÔÚ²¸Èéϸ°ûÖÐ˲ʱ¼°¸ßˮƽµØ±í´ïshRNA»òÄ¿µÄÂѰ×ÖÊ¡£
Æä¾ß±¸ÒÔÏÂÓŵ㣺
1. ËÞÖ÷¹æÄ£¹ã£ºÏÙ²¡¶¾³ý¿ÉѬȾһϵÁв¸È鶯Îïϸ°û,³ý¿ÉѬȾÏÕЩËùÓÐÈ˵Äϸ°ûÀàÐÍÍâ £¬»¹¿ÉѬȾ°üÀ¨´óÊó¡¢Ð¡Êó¡¢Íá¢Öí¡¢Ñò¡¢ºï¡¢¼¦µÈÎïÖÖ¡£
2. ÒòÏÙ²¡¶¾µÄѬȾ²»ÒÀÀµÏ¸°ûÖÜÆÚ £¬¹ÊÆä¼È¿ÉÒÔѬȾÔöֳϸ°ûÒ²¿ÉÒÔѬȾ·ÇÔöֳϸ°û¡£
3. ˲ʱ¸ßЧ±í´ï £¬²»ÕûºÏµ½»ùÒò×éÖС£
4. ²¡¶¾µÎ¶È¸ß £¬¿ÉÓÃÓÚ¶¯ÎïˮƽµÄʵÑé¡£
 
±¾ÏµÍ³ÊÇÒÔAd5ѪÇåÐÍE1/E3ȱÏÝÐÍÏÙ²¡¶¾DNAΪ¹Ç¼Ü¡¢ÔÚ¿Ë¡¡¢°ü×°¡¢À©ÔöµÈ¸÷²¿Ìõ¼þ×öÁËˢкÍÓÅ»¯ £¬µÖ´ïÁ˿ˡÑôÐÔÂʸü¸ß £¬ÖÊÁ¿¸ü¿É¿¿ £¬°ü×°ÎȹÌ £¬³ö¶¾Ñ¸ËÙ £¬µÎ¶È¸ßµÈЧ¹û¡£Ëù°ü×°µÄÏÙ²¡¶¾ÒÑÀÖ³ÉÓ¦ÓÃÓÚµòÍö¼ì²â¡¢È¾É«ÖÊÃâÒß³Áµí£¨ChIP£©¡¢RT-PCR¡¢Co-IPµÈ¿ÆÑÐʵÑé¡£
 

¶þ¡¢ÊµÑé°ì·¨¼°ÖÜÆÚ£º

1. ½«Ä¿µÄ»ùÒò²åÈëÏÙ²¡¶¾ÖØ´©ËóÖÊÁ£ÖÐ £¬ÊµÑéÖÜÆÚΪ7¸öÊÂÇéÈÕ £¬ ÈçÒªÇó¶ÔÔØÌåµÄÌØ¶¨²¿¼þÓÐËùÒªÇó¶øÐè¾ÙÐÐÌØÊâˢР£¬Ôò´Ë²½ÊµÑéõè¾¶¼°ÊµÑéÖÜÆÚÁíÐл®¶¨¡£
2. ½«Ä¿µÄ»ùÒò×ªÒÆÖÁÏÙ²¡¶¾¹Ç¼ÜÖÐ £¬ÊµÑéÖÜÆÚΪ7¸öÊÂÇéÈÕ¡£
3. ½«È·¶¨×¼È·µÄÖØ×éÏÙ²¡¶¾ÖÊÁ£ÔÚ293Aϸ°û¾ÙÐаü×° £¬Ê±¼äԼΪ20¸öÊÂÇéÈÕ¡£
4. ÏÙ²¡¶¾À©ÔöºÍCsCl´¿»¯ £¬ÊµÑéÖÜÆÚΪ7¸öÊÂÇéÈÕ¡£
5. ¶Ô°ü×°³öµÄÖØ×鲡¶¾¾ÙÐÐÖʼì¡£
Öʼì°üÀ¨¶ÔÖÕ²úÆ·²¡¶¾»ùÒò¾ÙÐÐPCRºÍWBÒÔÈ·ÈÏÄ¿µÄ»ùÒòµÄ±£´æ £¬ÊµÑéÖÜÆÚΪ5¸öÊÂÇéÈÕ¡£
 

Èý¡¢Ð§ÀÍÔÊÐí£º

1. ÌṩµÄ²¡¶¾Á¿Îª1mlµÎ¶È>1010VP/ml £¬ÈçÐè¸ü´óÅúµÄ²¡¶¾ÇëÏêϸÔÙÉÌÇ¢¡£
2. Ìṩ´©ËóÖÊÁ£ £¬ÖØ×éÏÙ²¡¶¾ÖÊÁ£¼°Ïà¹ØÃ¸ÇÐÅжϵçӾͼ £¬²âÐò±¨¸æ¡¢ÖÕ²úÆ·PCR»òWBÅжϵÄʵÑ鱨¸æ¡£
3. ΪÁËÈ·±£Ð§ÀÍÖÊÁ¿ £¬ÌõÔ¼ÖÜÆÚΪÔÚʵÑéÖÜÆÚµÄ»ù´¡ÉϼÓ10¸öÊÂÇéÈÕ¡£
 

ËÄ¡¢Ó¦ÓÃʵÀý£º

 
ÏÙ²¡¶¾Ñ¬È¾Ô­´úÉñ¾­Ôª
 ×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!
Fig1:Infection efficiency of Ad-Fos in CGNs. DIV5 CGNs were infected with Ad-Fos at MOI of 100. Thirty six hours after infection phase-contrast light and fluorescent micrographs of the infected cells were visualized. The cells infected with Ad-Fos were fixed and were stained with a Flag-specific M2 antibody or without a primary antibody (-1¡ã). Infection efficiency of adenovirus is about 80%.
Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿